# Utility of Pharmacogenomic Testing in Patients With Gastrointestinal Disorders

> **NCT05572593** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 97 (actual)

## Conditions studied

- Gastrointestinal Diseases

## Interventions

- **GENETIC:** Pharmacogenomics (PGx) genetic testing

## Key facts

- **NCT ID:** NCT05572593
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-08
- **Primary completion:** 2021-09-15
- **Final completion:** 2021-09-15
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05572593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05572593, "Utility of Pharmacogenomic Testing in Patients With Gastrointestinal Disorders". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05572593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*